Last reviewed · How we verify
salicylic acid and ciclopirox olamine
salicylic acid and ciclopirox olamine is a Topical antifungal/keratolytic combination Small molecule drug developed by Federal University of São Paulo. It is currently FDA-approved for Fungal skin infections (dermatophytosis, candidiasis), Onychomycosis (nail fungal infections), Bacterial skin infections. Also known as: anti-seborrheic treatment, anti-dandruff treatment.
Salicylic acid and ciclopirox olamine work synergistically to treat fungal and bacterial skin infections by keratolytic action and antifungal/antibacterial activity.
Salicylic acid and ciclopirox olamine work synergistically to treat fungal and bacterial skin infections by keratolytic action and antifungal/antibacterial activity. Used for Fungal skin infections (dermatophytosis, candidiasis), Onychomycosis (nail fungal infections), Bacterial skin infections.
At a glance
| Generic name | salicylic acid and ciclopirox olamine |
|---|---|
| Also known as | anti-seborrheic treatment, anti-dandruff treatment |
| Sponsor | Federal University of São Paulo |
| Drug class | Topical antifungal/keratolytic combination |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | FDA-approved |
Mechanism of action
Salicylic acid is a keratolytic agent that softens and removes dead skin cells, enhancing penetration of the antifungal agent. Ciclopirox olamine is a broad-spectrum antifungal and antibacterial agent that disrupts fungal cell membrane integrity and inhibits fungal enzyme systems. Together, they provide enhanced efficacy against dermatophytes, yeasts, and bacteria in topical skin infections.
Approved indications
- Fungal skin infections (dermatophytosis, candidiasis)
- Onychomycosis (nail fungal infections)
- Bacterial skin infections
Common side effects
- Local irritation
- Erythema
- Pruritus
- Contact dermatitis
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- salicylic acid and ciclopirox olamine CI brief — competitive landscape report
- salicylic acid and ciclopirox olamine updates RSS · CI watch RSS
- Federal University of São Paulo portfolio CI
Frequently asked questions about salicylic acid and ciclopirox olamine
What is salicylic acid and ciclopirox olamine?
How does salicylic acid and ciclopirox olamine work?
What is salicylic acid and ciclopirox olamine used for?
Who makes salicylic acid and ciclopirox olamine?
Is salicylic acid and ciclopirox olamine also known as anything else?
What drug class is salicylic acid and ciclopirox olamine in?
What development phase is salicylic acid and ciclopirox olamine in?
What are the side effects of salicylic acid and ciclopirox olamine?
Related
- Drug class: All Topical antifungal/keratolytic combination drugs
- Manufacturer: Federal University of São Paulo — full pipeline
- Therapeutic area: All drugs in Dermatology
- Indication: Drugs for Fungal skin infections (dermatophytosis, candidiasis)
- Indication: Drugs for Onychomycosis (nail fungal infections)
- Indication: Drugs for Bacterial skin infections
- Also known as: anti-seborrheic treatment, anti-dandruff treatment
- Compare: salicylic acid and ciclopirox olamine vs similar drugs
- Pricing: salicylic acid and ciclopirox olamine cost, discount & access